×
About 2,803 results

ALLMedicine™ Liver Transplants Center

Research & Reviews  773 results

Native liver survivors of portoenterostomy for biliary atresia with excellent outcome: ...
https://doi.org/10.1007/s00383-022-05313-w
Pediatric Surgery International; Tsuboi K, Watayo H et. al.

Dec 2nd, 2022 - Native liver survivors (NLS) after portoenterostomy (PE) for biliary atresia (BA) with normal biomarkers defined as total bilirubin (T-Bil), aspartate aminotransferase (AST)/alanine aminotransferase (ALT) for liver function (LF), cholinesterase (C...

Optimizing Survival for Hepatocellular Carcinoma After Liver Transplantation: A Single-...
https://doi.org/10.1016/j.transproceed.2022.10.048
Transplantation Proceedings; Nagy G, Gerlei Z et. al.

Nov 23rd, 2022 - Hepatocellular carcinoma (HCC) is the leading primary liver tumor and a main indication for transplant. Transplant criteria are based on clinicopathologic features, meanwhile adequate downstaging and molecular mechanisms are getting more attention...

Is Liver Transplant Justified at Any MELD Score?
https://doi.org/10.1097/TP.0000000000004345
Transplantation Oden-Brunson H, McDonald MF et. al.

Nov 12th, 2022 - Assessing the survival benefit of transplantation in patients with end-stage liver disease is critical in guiding the decision-making process for liver allocation. Previous studies established increased mortality risk for those transplanted below ...

Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscl...
https://doi.org/10.1007/s00345-022-04188-9
World Journal of Urology; Simonet M, Dominguez Gutierrez A et. al.

Nov 12th, 2022 - Urothelial carcinoma has a higher incidence in renal transplanted patients according to several registries (relative risk × 3), and the global prognosis is inferior to the general population. The potential impact of immunosuppressive therapy on th...

Long-term outcomes of retransplantation after live donor liver transplantation: A Weste...
https://doi.org/10.1016/j.surg.2022.09.022
Surgery Ivanics T, Limkemann A et. al.

Nov 6th, 2022 - Despite most liver transplants in North America being from deceased donors, the number of living donor liver transplants has increased over the last decade. Although outcomes of liver retransplantation after deceased donor liver transplantation ha...

see more →

Guidelines  1 results

Society for the Advancement of Transplant Anesthesia: Liver Transplant Anesthesia Fello...
https://doi.org/10.1177/1089253217737043
Seminars in Cardiothoracic and Vascular Anesthesia; Chadha RM, Crouch C et. al.

Oct 17th, 2017 - The anesthesia community has openly debated if the care of transplant patients was generalist or specialist care ever since the publication of an opinion paper in 1999 recommended subspecialty training in the field of liver transplantation anesthe...

see more →

Drugs  78 results see all →

Clinicaltrials.gov  52 results

A2 to O Lung Transplants
https://clinicaltrials.gov/ct2/show/NCT05581745

Oct 14th, 2022 - Blood group A2 to blood group O kidney and liver transplants have been shown to be safe and successful, especially in recipients with low pre-operative anti-A antibody titers and with the use of peri-operative antibody-depleting therapies. Since b...

Craniomaxillofacial Allotransplantation
https://clinicaltrials.gov/ct2/show/NCT02158793

Oct 5th, 2022 - This study is to perform facial transplants in patients with severe facial deformities or facial wounds from traumatic injuries. The transplant is to help reconstruct a person's damaged face. The aim of the transplant is to provide patient a more ...

OCS Liver DCD Trial
https://clinicaltrials.gov/ct2/show/NCT04194437

Sep 13th, 2022 - To evaluate the safety and effectiveness of the OCS™ Liver to preserve, optimize the condition and assess livers from DCD donors that currently are seldom used for liver transplants due to limitations of cold static storage with extended warm isch...

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
https://clinicaltrials.gov/ct2/show/NCT03193151

Aug 22nd, 2022 - The current standard for biopsy-based diagnoses of dysfunction of liver transplants is histology (the Banff system), an arbitrary international empirical consensus based on lesions and rules, similar in principle to the kidney, heart, and lung his...

Pilot Study of the Liver Live Donor Champion Program
https://clinicaltrials.gov/ct2/show/NCT03580629

Aug 18th, 2022 - In the United States, more than 13,000 patients are on the waiting list to receive a liver transplant. Although more than 6,000 liver transplants are performed every year, at least 1,700 patients die each year while on the waiting list. Livers are...

see more →

News  196 results

Living Donor Liver Transplants on Rise for Most Urgent Need
https://www.medscape.com/viewarticle/983967

Nov 12th, 2022 - Living donor liver transplants (LDLT) for recipients with the most urgent need for a liver transplant in the next 3 months – a model for end-stage liver disease (MELD) score of 25 or higher – have become more frequent during the past decade, accor...

Real-world evidence seen for metal stents in biliary strictures
https://www.mdedge.com/internalmedicine/article/258594/gastroenterology/real-world-evidence-seen-metal-stents-biliary
Jim Kling

Oct 12th, 2022 - A real-world analysis in the United Kingdom found that a fully covered metal stent is safe and effective at controlling anastomotic strictures (AS) following liver transplants. Biliary AS occurs in an estimated 5%-32% of patients following a liver.

Obeticholic Acid Tied to Better Outcomes in Primary Biliary Cholangitis
https://www.medpagetoday.com/gastroenterology/generalhepatology/100862

Sep 22nd, 2022 - Patients with primary biliary cholangitis (PBC) on obeticholic acid (Ocaliva) had better transplant-free survival compared with those who did not receive the treatment, according to an analysis using participants from the randomized POISE trial. O...

Living-Donor Liver Transplant Tied to Substantial Survival Benefit
https://www.medscape.com/viewarticle/980212

Sep 2nd, 2022 - Living-donor liver transplant recipients gained an additional 13-17 years of life, compared with patients who remained on the wait list, according to a retrospective case-control study. Dr Whitney Jackson The data suggest that the life-years gaine...

Living-donor liver transplants linked with substantial survival benefit
https://www.mdedge.com/internalmedicine/article/257519/hepatology/living-donor-liver-transplants-linked-substantial
Carolyn Crist

Sep 1st, 2022 - Living-donor liver transplant recipients gained an additional 13-17 years of life, compared with patients who remained on the wait list, according to a retrospective case-control study. The data suggest that the life-years gained are comparable to.

see more →

Patient Education  21 results see all →